Gender differences in the influence of escitalopram on prolac-tin levels in patients with first-episode depression

Liu Na,Liu Wenwen,Sun Qianming,Song Yanyan,Shao yudan,Li Zheng,Zhai Yongli,Fu Huipeng,Li Meng,Kong Derong

DOI: https://doi.org/10.3969/j.issn.1672-187x.2023.02.005

2023-01-01

Abstract:Objective To explore the gender differences in the influence of escitalopram on serum prolactin levels in patients with first-episode depression.Methods A total of 121 hospitalized patients with first depressive episode were retrospectively analyzed,divided into male research（n=57） and female group（n=64） according to genders,prolactin levels at baseline and at the end of 4 weeks of treatment collected,and so did the total scores on the Hamilton Depression Scale（HAMD-17） and side reactions at baseline,at the end of 4 weeks of treatment and on discharge;fifty-seven healthy males and 64 females matched with research groups were assigned to control group.Results On baseline,there were significant differences in prolactin levels among the four groups（P＜0.001）,differences between male research and control group as well as female research and control group had no statistical significance（P＞ 0.05）;at the end of 4weeks of treatment prolactin levels elevated in male and female research groups compared with baseline,but difference only in female research group had statistical significance（P＜0.05）.At the end of 4 weeks of treatment prolactin levels in male research group and female research group were higher than those in baseline period,but there was statistical significance in female research group（P＜0.05）.At the end of 4weeks,the incidence of hyperprolactinemia was respectively 7.02% in male and 20.31 % in female research group,the difference was statistically significant（P＜0.005）.Conclusion Serum prolactin levels elevate in patients with first-episode depression and the elevation is more obvious in female than male ones.